Chaman Lal | Management and Accounting | Best Researcher Award

Dr. Chaman Lal | Management and Accounting | Best Researcher Award

Associate Professor at Central University of Himachal Pradesh, India.

Dr. Chaman Lal is an accomplished Associate Professor at the School of Commerce and Management Studies, Central University of Himachal Pradesh. With a robust academic background and extensive experience in marketing and entrepreneurship, he has made significant contributions to research, particularly in rural marketing and entrepreneurship. Dr. Lal has published numerous research papers in prestigious journals and has taken an active role in mentoring students at the MPhil and PhD levels. His dedication to academic excellence and policy development is further exemplified by his involvement in research projects that benefit the Government of India. In addition to his academic role, he serves as the Honorary Director of the Centre for Entrepreneurship & Innovation, where he promotes entrepreneurial initiatives and innovation. His commitment to enhancing knowledge in his field and fostering a collaborative academic environment makes him a prominent figure in research and education.

Professional Profile

Education

Dr. Chaman Lal holds an impressive educational background, which includes a PhD, M.Phil, and M.Com. His advanced degrees demonstrate a deep understanding of the principles and practices within the fields of marketing and entrepreneurship. This strong academic foundation equips him with the theoretical knowledge necessary to navigate complex research challenges effectively. His PhD research focuses on rural marketing, addressing critical issues relevant to India’s socio-economic landscape. This rigorous academic training has laid the groundwork for his extensive research endeavors and his capacity to guide and mentor students pursuing advanced degrees. Dr. Lal’s commitment to lifelong learning and academic excellence is evident in his ongoing pursuit of knowledge and his dedication to contributing to the field through education and research. Overall, his educational qualifications reflect a well-rounded scholar poised to make impactful contributions to academia and society.

Professional Experience

Dr. Chaman Lal has garnered diverse professional experience throughout his career, primarily in academic roles. He began his journey as an Assistant Professor at the Department of Higher Education, Government of Himachal Pradesh, where he honed his teaching skills and developed a strong foundation in higher education. He then joined the School of Management Studies (SOMS) at Indira Gandhi National Open University (IGNOU), where he further expanded his expertise in marketing and entrepreneurship. Currently, as an Associate Professor at the Central University of Himachal Pradesh, he plays a pivotal role in shaping the academic landscape through his teaching and research contributions. Dr. Lal’s professional journey is marked by a commitment to fostering student engagement and promoting innovative teaching methodologies. His leadership as the Honorary Director of the Centre for Entrepreneurship & Innovation underscores his dedication to encouraging entrepreneurial initiatives and bridging the gap between academia and industry. Through his diverse professional experiences, Dr. Lal has established himself as a respected educator and researcher.

Research Interests

Dr. Chaman Lal’s research interests are primarily focused on rural marketing, rural retailing, and entrepreneurship, reflecting his commitment to addressing the unique challenges faced by rural communities in India. His exploration of rural marketing strategies aims to enhance the effectiveness of marketing practices in less urbanized regions, thereby contributing to the economic empowerment of these communities. Dr. Lal’s research in entrepreneurship emphasizes fostering innovation and developing sustainable business models that can thrive in rural settings. His interest in rural retailing further investigates the dynamics of supply chains and consumer behavior in these areas. Through his research endeavors, Dr. Lal seeks to bridge the gap between theory and practice, providing valuable insights that can inform policymakers and practitioners. His dedication to these topics not only contributes to academic discourse but also has practical implications for improving the socio-economic conditions of rural populations. As he continues to expand his research horizons, Dr. Lal remains committed to making a positive impact on society through his scholarly work.

Research Skills

Dr. Chaman Lal possesses a diverse set of research skills that enable him to conduct rigorous and impactful studies. His expertise in qualitative and quantitative research methodologies allows him to design comprehensive studies that yield meaningful insights into rural marketing and entrepreneurship. Proficient in data analysis techniques, he employs statistical tools to interpret complex datasets and draw valid conclusions. Dr. Lal’s ability to synthesize information from various sources contributes to his capacity to develop well-informed policy documents and knowledge heritage documents for the Government of India. His experience in supervising MPhil and PhD students further showcases his skill in guiding emerging researchers in their academic pursuits. Additionally, Dr. Lal’s active participation in national and international seminars reflects his commitment to engaging with the broader academic community, sharing knowledge, and collaborating with peers. Through these research skills, he continues to advance knowledge in his field and contribute to the development of effective strategies for rural marketing and entrepreneurship.

Awards and Honors

Dr. Chaman Lal has been recognized for his exceptional contributions to academia and research, receiving several awards and honors throughout his career. Notably, he was awarded the Best Researcher Award, highlighting his commitment to scholarly excellence and impactful research in marketing and entrepreneurship. This prestigious accolade reflects his ability to produce high-quality research that resonates with both academic and practical audiences. Additionally, his role as a lifetime member of The Indian Commerce Association demonstrates his active engagement with professional communities dedicated to advancing commerce and management studies. Dr. Lal’s involvement in various research projects, including policy documents and knowledge heritage initiatives for the Government of India, further underscores his influence in the field. These achievements not only recognize his individual efforts but also contribute to the broader academic community, enhancing the reputation of his institution and inspiring fellow researchers and students. Dr. Lal’s dedication to excellence continues to drive his work and influence the next generation of scholars.

Conclusion:

Dr. Chaman Lal’s extensive academic qualifications, robust research output, and active participation in the academic community position him as a strong candidate for the Best Researcher Award. His contributions to rural marketing and entrepreneurship not only advance academic knowledge but also have significant implications for policy and practice in India. By addressing the identified areas for improvement, he can further enhance his impact and continue to be a leading figure in his field.

Publications Top Notes

  1. Eco-toxicological effects assessment: comparative characteristics of environmental conditions and Dynamically crosslinked ECM-like hydrogels loaded with ROS-responsive drug nanoparticles for treating inflammation in myocardial infarction and stroke
    • Authors: Wang, Z., Hu, C., Zhang, W., Yang, L., Wang, Y.
    • Year: 2024
  2. Effects of flavor components of sauce-flavor Baijiu on ethanol metabolism and key enzyme activities in mice | 酱香型白酒风味成分对小鼠乙醇代谢及关键酶活性的影响
    • Authors: Han, R., Fang, S., Xia, Y., Zhao, Y., Hu, C.
    • Year: 2024
  3. Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels
    • Authors: Zhang, W., Liu, Y., Wang, Z., Hu, C., Wang, Y.
    • Year: 2024
  4. Progress of Research on Conductive Hydrogels in Flexible Wearable Sensors
    • Authors: Cao, J., Wu, B., Yuan, P., Liu, Y., Hu, C.
    • Year: 2024
  5. A Whole-Course-Repair System Based on Stimulus-Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration
    • Authors: Liu, W., Long, L., Wang, Z., Hu, C., Wang, Y.
    • Year: 2024
  6. An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction
    • Authors: Liu, W., Hu, C., Long, L., Yang, L., Wang, Y.
    • Year: 2024
  7. A Versatile Glycopeptide Hydrogel Promotes Chronic Refractory Wound Healing Through Bacterial Elimination, Sustained Oxygenation, Immunoregulation, and Neovascularization
    • Authors: Wu, Y., Wang, Y., Zheng, C., Zhang, H., Wang, Y.
    • Year: 2023
  8. Rational Design of Multifunctional Hydrogels for Wound Repair
    • Authors: Cao, J., Wu, B., Yuan, P., Liu, Y., Hu, C.
    • Year: 2023
  9. Polyphenol-mediated sandwich-like coating promotes endothelialization and vascular healing
    • Authors: Wan, H., Li, Y., Qin, Y., Zhang, B., Wang, Y.
    • Year: 2023
  10. Combining HUMSC secretome and a conductive hydrogel enhances angiogenesis and electrical transmission at myocardial infarct sites to support cardiac repair
    • Authors: He, S.-Y., Long, L.-Y., Wang, Z.-C., Li-Yang, Wang, Y.-B.
    • Year: 2023

 

 

 

 

Cheng Hu | Materials Science | Excellence in Innovation

Assoc Prof Dr. Cheng Hu | Materials Science | Excellence in Innovation

Associate Professor at Sichuan University, China.

Cheng Hu is an accomplished Associate Professor at Sichuan University, specializing in biomaterials and biomedical engineering. With a profound focus on developing innovative microenvironment-responsive delivery systems, Hu’s research addresses critical biomedical challenges such as myocardial infarction and stroke. His work emphasizes the integration of smart biomaterials, hydrogels, and organic synthesis within the realm of materials chemistry. An active contributor to the academic community, Hu has a robust publication record, including numerous articles in high-impact journals, showcasing his commitment to advancing scientific knowledge and improving patient outcomes. His collaborative efforts extend across multiple disciplines, enhancing the translational potential of his research. Hu is recognized for his editorial contributions to various journals, demonstrating his dedication to fostering innovation in the field of biomedical engineering. Through his innovative approach, he aims to bridge the gap between research and clinical applications, ultimately improving healthcare delivery and patient care.

Professional Profile

Education

Cheng Hu earned his Ph.D. in Biomedical Engineering, where he focused on the synthesis and characterization of novel biomaterials for medical applications. His educational journey laid a solid foundation in materials chemistry, enabling him to explore complex interactions between biomaterials and biological systems. During his doctoral studies, he honed his skills in hydrogel development and drug delivery mechanisms, paving the way for his future research endeavors. Following his Ph.D., Hu continued to expand his expertise through postdoctoral research positions, where he collaborated with leading experts in the field. This experience enriched his knowledge of smart materials and their applications in regenerative medicine. Hu’s comprehensive educational background equips him with the theoretical understanding and practical skills necessary to tackle pressing challenges in biomedical engineering, making him a valuable contributor to the academic and scientific communities.

Professional Experience

Cheng Hu currently serves as an Associate Professor at the National Engineering Research Center for Biomaterials at Sichuan University, where he has been since July 2021. In this role, he leads various research projects focusing on smart biomaterials and drug delivery systems. Prior to this position, Hu gained significant experience in both academic and industrial settings, contributing to multidisciplinary teams that aimed to develop innovative solutions for biomedical challenges. His work involves extensive collaboration with clinicians and researchers, facilitating the translation of research findings into practical applications. Hu has also participated in numerous international conferences, presenting his findings and engaging with peers in the field. His professional experience has established him as a respected figure in biomedical engineering, known for his dedication to research excellence and innovation. Through his leadership and mentorship, Hu inspires the next generation of scientists while advancing the field of biomaterials.

Research Interests

Cheng Hu’s primary research interests lie in the development of microenvironment-responsive delivery systems, with a strong emphasis on smart biomaterials and their biomedical applications. His work focuses on innovative approaches to drug delivery, particularly through the use of hydrogels that respond to physiological stimuli. This includes exploring their potential in treating conditions such as myocardial infarction and stroke. Additionally, Hu is passionate about the construction of multifunctional hydrogels that integrate anti-inflammatory and pro-angiogenic properties for enhanced tissue regeneration. His research extends to the field of cardiovascular diseases, where he aims to create materials that improve patient outcomes through targeted therapies. By investigating the interplay between materials chemistry and biomedical engineering, Hu seeks to bridge the gap between basic research and clinical applications, ultimately contributing to the advancement of regenerative medicine.

Research Skills

Cheng Hu possesses a diverse array of research skills that underpin his contributions to biomaterials and biomedical engineering. His expertise encompasses the synthesis and characterization of novel hydrogels and biomaterials, employing techniques such as organic synthesis, materials chemistry, and polymer science. Hu is proficient in developing and optimizing drug delivery systems that respond to specific physiological triggers, enhancing therapeutic efficacy. Additionally, he has strong analytical skills, enabling him to conduct in-depth evaluations of material properties and their interactions with biological systems. His proficiency in various characterization techniques, including spectroscopy and microscopy, further strengthens his research capabilities. Hu is also experienced in collaborating with interdisciplinary teams, fostering communication and innovation in project development. His commitment to rigorous scientific methodology and continuous learning enables him to stay at the forefront of advancements in biomaterials and biomedical research.

Awards and Honors

Cheng Hu has received numerous accolades for his contributions to the field of biomedical engineering, recognizing his innovative research and commitment to excellence. His work has been published in high-impact journals, garnering citations and praise from peers worldwide. Hu has been invited to present his research at prestigious international conferences, showcasing his role as a leader in the field. His editorial involvement with various academic journals highlights his recognition as an expert in biomaterials, further solidifying his reputation within the scientific community. Additionally, he has been acknowledged for his collaborative efforts, receiving funding for several research projects aimed at advancing smart biomaterials for medical applications. These awards and honors reflect Hu’s dedication to pushing the boundaries of biomedical engineering and his ongoing contributions to improving patient care through innovative research.

Conclusion:

Cheng Hu is a commendable candidate for the Excellence in Innovation award, demonstrating a strong foundation in biomedical research with notable contributions to smart biomaterials. His innovative approaches to drug delivery and tissue engineering are poised to make significant impacts in clinical applications. By addressing the suggested areas for improvement, he could further enhance his influence and leadership in the field, ensuring that his research translates into meaningful innovations for patient care.

Publications Top Notes

  1. Eco-toxicological effects assessment: comparative characteristics of environmental conditions and Dynamically crosslinked ECM-like hydrogels loaded with ROS-responsive drug nanoparticles for treating inflammation in myocardial infarction and stroke
    • Authors: Wang, Z., Hu, C., Zhang, W., Yang, L., Wang, Y.
    • Year: 2024
  2. Effects of flavor components of sauce-flavor Baijiu on ethanol metabolism and key enzyme activities in mice | 酱香型白酒风味成分对小鼠乙醇代谢及关键酶活性的影响
    • Authors: Han, R., Fang, S., Xia, Y., Zhao, Y., Hu, C.
    • Year: 2024
  3. Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels
    • Authors: Zhang, W., Liu, Y., Wang, Z., Hu, C., Wang, Y.
    • Year: 2024
  4. Progress of Research on Conductive Hydrogels in Flexible Wearable Sensors
    • Authors: Cao, J., Wu, B., Yuan, P., Liu, Y., Hu, C.
    • Year: 2024
  5. A Whole-Course-Repair System Based on Stimulus-Responsive Multifunctional Hydrogels for Myocardial Tissue Regeneration
    • Authors: Liu, W., Long, L., Wang, Z., Hu, C., Wang, Y.
    • Year: 2024
  6. An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction
    • Authors: Liu, W., Hu, C., Long, L., Yang, L., Wang, Y.
    • Year: 2024
  7. A Versatile Glycopeptide Hydrogel Promotes Chronic Refractory Wound Healing Through Bacterial Elimination, Sustained Oxygenation, Immunoregulation, and Neovascularization
    • Authors: Wu, Y., Wang, Y., Zheng, C., Zhang, H., Wang, Y.
    • Year: 2023
  8. Rational Design of Multifunctional Hydrogels for Wound Repair
    • Authors: Cao, J., Wu, B., Yuan, P., Liu, Y., Hu, C.
    • Year: 2023
  9. Polyphenol-mediated sandwich-like coating promotes endothelialization and vascular healing
    • Authors: Wan, H., Li, Y., Qin, Y., Zhang, B., Wang, Y.
    • Year: 2023
  10. Combining HUMSC secretome and a conductive hydrogel enhances angiogenesis and electrical transmission at myocardial infarct sites to support cardiac repair
    • Authors: He, S.-Y., Long, L.-Y., Wang, Z.-C., Li-Yang, Wang, Y.-B.
    • Year: 2023

 

 

 

 

Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

Dr. Tal Golan Lagziel | Medicine and Dentistry | Best Researcher Award

MD PhD (resident in pediatrics) at Sheba Medical Center, Israel.

Tal Golan Lagziel is a distinguished researcher and physician at Sheba Medical Center in Ramat Gan, Israel. He holds an M.D. and Ph.D. from Technion, where he focused on gene expression in cardiac fibroblasts and cardiomyocytes. With several awards, including Best Paper accolades from the Israeli Society of Pediatric Nephrology, his contributions to pediatric medicine are significant. Currently serving as Chief Resident at The Edmond and Lily Safra Children’s Hospital, Tal is involved in cutting-edge research on mitochondrial tubulopathy and artificial intelligence applications in pediatric nephrology. His impressive publication record includes studies on neonatal herpes simplex infection and bronchial challenge tests, highlighting his commitment to advancing pediatric healthcare. Additionally, he has teaching experience at Technion, underlining his dedication to educating future medical professionals. Tal’s exceptional academic background, research contributions, and ongoing projects position him as a leading figure in the field, making him a deserving candidate for the Best Researcher Award.

Profile:

Education

Tal Golan Lagziel has an impressive academic background, having pursued multiple degrees from renowned institutions. He completed his Ph.D. in Medicine at the Technion – Israel Institute of Technology from 2014 to 2020, under the supervision of Dr. Itzhak Kehat. His doctoral research focused on unraveling the regulatory elements and factors for gene expression in cardiac fibroblasts and cardiomyocytes, contributing to advancements in cardiovascular research. Alongside his Ph.D., he earned his M.D. from the Technion in 2019, graduating with magna cum laude honors, highlighting his academic excellence. Prior to this, he completed a B.Sc. in Medical Sciences and a B.Sc. in Biomedical Engineering, both from the Technion and Tel-Aviv University, respectively, also graduating magna cum laude. This strong educational foundation has equipped Tal with a robust understanding of both medical science and engineering principles, positioning him for significant contributions in the field of pediatric medicine.

Professional Experience

Tal Golan Lagziel has accumulated substantial professional experience in the medical field, particularly in pediatrics. Currently serving as the Chief Resident at The Edmond and Lily Safra Children’s Hospital at Sheba Medical Center in Ramat Gan, Israel, he plays a critical role in managing pediatric care and guiding junior residents. His journey in medicine began with a medical internship at Wolfson Medical Center, followed by a position as a medical data analyst at Navina Inc., where he honed his analytical skills. Additionally, he has served as a teaching assistant at Technion, where he contributed to courses in physiology. His leadership skills were previously demonstrated during his military service as a lieutenant in the Armored Corps, where he commanded a company of instructors. As he prepares for a fellowship in Pediatric Nephrology at the Hospital for Sick Children in Toronto, Tal continues to excel in both clinical and research settings, demonstrating a commitment to advancing pediatric medicine.

Research Interest

Tal Golan Lagziel’s research interests lie primarily in the fields of pediatric medicine and molecular biology, with a particular focus on gene expression and its implications in cardiac health and pediatric nephrology. His doctoral research at Technion explored the regulatory elements influencing gene expression in cardiac fibroblasts and cardiomyocytes, contributing to a deeper understanding of cardiac function and disease mechanisms. Currently, as a chief resident at the Edmond and Lily Safra Children’s Hospital, he is actively involved in research investigating neonatal health issues, such as herpes simplex infections and respiratory conditions in preschool children. Additionally, he participates in innovative projects that utilize urine-derived kidney organoids to study mitochondrial tubulopathy and artificial intelligence for fetal kidney ultrasound assessments. Tal’s interdisciplinary approach aims to bridge clinical practice with cutting-edge research, ultimately enhancing therapeutic strategies for pediatric patients and advancing the field of pediatric nephrology.

Research Skills

Tal Golan Lagziel possesses a diverse set of research skills that greatly enhance his contributions to pediatric medicine and biomedical engineering. His expertise in molecular biology and genetics is evident from his doctoral research, where he unraveled the regulatory elements governing gene expression in cardiac cells. Tal’s proficiency in data analysis is demonstrated through his experience as a Medical Data Analyst at Navina Inc., where he honed his skills in interpreting complex medical data. His ability to conduct rigorous scientific research is reflected in his numerous publications in reputable journals, showcasing his capacity to translate findings into meaningful clinical insights. Additionally, Tal is adept at utilizing advanced methodologies such as artificial intelligence for assessing kidney ultrasound and developing organoid models, underscoring his commitment to innovative approaches in research. Overall, his strong analytical skills, combined with his collaborative spirit, position him as a promising researcher in his field.

Award and Recognition

Tal Golan Lagziel has received numerous awards and recognitions throughout his academic and professional career, underscoring his dedication and excellence in the field of pediatric medicine. Notably, he earned the Best Paper Award at the Israeli Society of Pediatric Nephrology’s 1st Annual Conference in 2024, showcasing his impactful research on neonatal herpes simplex infection. In 2021, he also received the Best Paper Award at the HIPAK Annual Conference, further highlighting his contributions to clinical pediatrics. Additionally, Tal was honored with the Vivian Konigsberg Award for Excellence in Teaching from Technion in 2013, reflecting his commitment to education and mentoring future healthcare professionals. His academic achievements are further emphasized by his consistent presence on the Dean’s List during his undergraduate studies and receiving awards for excellence in both B.Sc. studies at Technion and Tel-Aviv University. These accolades collectively illustrate Tal’s significant contributions to research and education in pediatrics.

Conclusion

Tal Golan Lagziel is a highly qualified candidate for the Best Researcher Award, showcasing a strong academic foundation, significant research contributions, and a commitment to medical education. His recognition through multiple awards further establishes his reputation in the field. Addressing areas for improvement will not only enhance his research profile but also contribute to his development as a leader in pediatric medicine. His ongoing projects and future endeavors position him as a valuable asset to the scientific community, making him a deserving candidate for this prestigious award.

Publication Top Notes

  • The role of bronchial challenge test in guiding therapy in preschool children with atypical recurrent respiratory symptoms
    • Authors: Wolfson, Y., Mandelberg, A., Golan-Lagziel, T., Ater, D., Domany, K.A.
    • Year: 2024
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 59(2), pp. 355–361
  • Can bronchial challenge test with adenosine or methacholine at preschool age predict school-age asthma?
    • Authors: Golan-Lagziel, T., Mandelberg, A., Wolfson, Y., Ater, D., Armoni Domany, K.
    • Year: 2021
    • Journal: Pediatric Pulmonology
    • Volume/Issue/Page: 56(10), pp. 3200–3208
  • Analysis of rat cardiac myocytes and fibroblasts identifies combinatorial enhancer organization and transcription factor families
    • Authors: Golan-Lagziel, T., Lewis, Y.E., Shkedi, O., Caspi, L.H., Kehat, I.
    • Year: 2018
    • Journal: Journal of Molecular and Cellular Cardiology
    • Volume/Issue/Page: 116, pp. 91–105

 

 

 

Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

 Dr. Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Dr. Alaa Alsalloum, Novosibirsk State University, Russia.

Dr. Alaa Alsalloum is a dedicated researcher in the fields of immunology and microbiology, known for her contributions to understanding immune responses and microbial interactions. With a strong commitment to excellence in research, she focuses on innovative approaches to tackle infectious diseases and enhance immunological health. Alaa’s work is characterized by a collaborative spirit and a passion for advancing scientific knowledge, making her a valuable asset in the pursuit of breakthroughs in health and disease management.

Profile:

Education

Alaa Alsalloum’s educational journey began at the National Center for Distinguished in Syria, where she completed high school from October 2011 to June 2014. She then earned her Bachelor of Science in Pharmacy from the University of Damascus, focusing on Biomedical Sciences, with a thesis titled “Phage Nanobody Immuno-PCR for Ultra-sensitive Detection of Growth Hormone (GH).” Following this, Alaa participated in a general education program at Kazan (Volga Region) Federal University to master professional educational programs in Russian from October 2018 to June 2019. She continued her studies at Kazan Federal University, where she completed her master’s degree in the Institute of Medicine and Biology, focusing on the earlier immune markers of multiple sclerosis in an animal model for her thesis. Currently, Alaa is pursuing her PhD at Novosibirsk State University, specializing in molecular immunology, with her research centered on the phenotypic and functional characteristics of T-lymphocytes with genetically modified antigen-recognizing receptors specific to solid tumor antigens.

 Interests

Alaa Alsalloum is committed to community service, having volunteered with the Association for Persons with Special Needs (APSN) in Deir Atiyah, Syria, from July 2014 to September 2015. During her time there, she contributed to supporting individuals with special needs, helping to enhance their quality of life and promote inclusivity. This experience reflects her dedication to making a positive impact in the lives of others and highlights her passion for service beyond her academic pursuits.

 Skills

Alaa Alsalloum possesses a robust set of technical skills acquired through her research in immunology and molecular biology during her Bachelor’s and Master’s theses. She is proficient in DNA and RNA extraction, PCR, electrophoresis, bacterial transformation, ELISA tests, immunochemistry, NanoString technology, and cell culture techniques. Additionally, she has experience with PBMC isolation, viral transduction of T-lymphocytes, dendritic cell differentiation protocols, tetramer assays, cell sorting protocols, flow cytometry, and intracellular flow cytometry staining. Alaa also has foundational knowledge in RT-PCR, cell analysis, Seahorse technology, 3D cell culture, and single-cell sequencing.On the interpersonal side, she has developed strong presentation and communication skills through participation in various seminars focused on communication and leadership. Alaa is adept at collaborating within a team while also demonstrating the ability to work independently, making her a well-rounded candidate in both research and professional settings.

 

Publication Top Notes

Alsalloum, A. (2024). NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy. Clinical and Translational Medicine. DOI: 10.1002/ctm2.70020. ISSN: 2001-1326.

Alsalloum, A. (2023). TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. Biomedicines, 11(10), Article 2805. DOI: 10.3390/biomedicines11102805.

Alsalloum, A. (2023). Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. International Journal of Molecular Sciences, 24(20), Article 15134. DOI: 10.3390/ijms242015134.

Alsalloum, A. (2023). Immunoregulatory properties of erythroid nucleated cells induced from CD34+ progenitors from bone marrow. PLOS ONE, 18(6), Article e0287793. DOI: 10.1371/journal.pone.0287793. ISSN: 1932-6203.

Alsalloum, A. (2023). The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? Cancers, 15(6), Article 1779. DOI: 10.3390/cancers15061779.

Alsalloum, A. (2022). Phenotypic and functional features of in vitro generated TCR-T cells specific for the tumor-associated antigen NY-ESO-1. Immunologiya, 43(5), 536-547. DOI: 10.33029/0206-4952-2022-43-5-536-547.

Alsalloum, A. (2022). Study of MAGE-A4 specific TCR-like CAR-T lymphocytes in vitro. Immunologiya, 43(4), 401-411. DOI: 10.33029/0206-4952-2022-43-4-401-411.

Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Assoc Prof Dr. Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

2004, EDA, Egypt

Dr. Omar Abdel-Hamed Ahmed-Farid is a highly qualified candidate for the Research for Best Researcher Award. With a robust academic and professional background, Dr. Farid has significantly impacted the field of physiology and analytical chemistry. His impressive citation metrics—1889 citations, an H-index of 24, and an I10-index of 61—highlight his influential research. As the Unit Administration Manager at the Egyptian Drug Authority, he excels in regulatory compliance, quality assurance, and team leadership. His previous roles include Technical Manager and Drug Quality Control Specialist, where he managed laboratory practices and ensured adherence to international standards. Dr. Farid’s contributions to policy development and staff training further demonstrate his dedication to advancing industry standards and professional excellence. His extensive research experience, combined with his leadership in regulatory and quality assurance roles, makes him a strong contender for this award.

Profile:

Education

Dr. Omar Abdel-Hamed Ahmed-Farid has a distinguished educational trajectory that underscores his expertise in physiology and analytical chemistry. He began his academic journey as an Assistant Researcher in Physiology in 2005, gradually advancing through roles as an Assistant Researcher, Researcher, and ultimately becoming an Associate Professor of Physiology in 2020. His progression reflects a deepening of knowledge and a growing commitment to the field. Dr. Farid’s education has been marked by hands-on experience and rigorous training in high-performance analytical techniques, such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC). This solid educational foundation has been instrumental in his success in research, quality assurance, and regulatory compliance within the pharmaceutical and medical diagnostics sectors. His academic background is a testament to his dedication to advancing scientific knowledge and improving industry standards

Professional Experience

Dr. Omar Abdel-Hamed Ahmed-Farid’s professional experience showcases a profound impact on the fields of physiology and analytical chemistry. As the Unit Administration Manager of Diagnostic Kits and Medical Supplies at the Egyptian Drug Authority (EDA), he oversees regulatory compliance, quality assurance, and documentation, ensuring adherence to national and international standards. His previous role as Technical Manager involved the implementation and maintenance of ISO-17025 and GLP standards, critical for maintaining laboratory accuracy and reliability. Dr. Farid’s extensive experience also includes managing laboratory equipment procurement and validation, as well as training staff on analytical techniques and quality protocols. His contributions to policy development and regulatory practices highlight his leadership and commitment to advancing industry standards. His career trajectory, from Drug Quality Control Specialist to Associate Professor, reflects a deep and evolving expertise, underpinned by a dedication to both scientific excellence and professional development.

Research Skill

Dr. Omar Abdel-Hamed Ahmed-Farid possesses a robust set of research skills, underscored by his extensive experience and academic background. His proficiency in analytical techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and Spectrophotometry highlights his capability to conduct precise and comprehensive biochemical analyses. Dr. Farid has demonstrated expertise in determining neurotransmitters, amino acids, and cellular metabolites, utilizing advanced methods like Atomic Absorption Spectroscopy and ELISA techniques. His research includes investigating enzymatic and non-enzymatic antioxidants, analyzing tissue samples using the Comet Assay, and studying animal blood pressure. His ability to apply complex analytical methods and maintain high standards in research protocols is further evidenced by his contributions to method validation and compliance with international standards. Dr. Farid’s analytical skills, combined with his commitment to quality and innovation, underscore his exceptional research capabilities.

Award and Recognition

Dr. Omar Abdel-Hamed Ahmed-Farid has demonstrated exceptional expertise and dedication in the field of physiology and analytical chemistry, earning widespread recognition for his impactful research and professional contributions. With 1889 citations, an H-index of 24, and a Researchgate score of 46.42, his scholarly work has significantly influenced the scientific community. As the Unit Administration Manager at the Egyptian Drug Authority, Dr. Farid has excelled in ensuring regulatory compliance, maintaining high-quality standards, and leading a team dedicated to advancing diagnostic practices. His commitment to policy development, training, and innovation underscores his role as a pivotal figure in the industry. Dr. Farid’s achievements reflect a remarkable blend of academic excellence and practical impact, making him a distinguished candidate for the Research for Best Researcher Award.

Conclusion

Dr. Omar Abdel-Hamed Ahmed-Farid’s comprehensive research contributions, extensive professional experience, and leadership in regulatory and quality assurance roles make him a highly suitable candidate for the Research for Best Researcher Award. His impact on the field through his research, coupled with his commitment to advancing regulatory practices and training, aligns well with the criteria for this prestigious award.

Publication Top Notes

  • Publication Title: Recombinant Interleukin − 2 Immunotherapy Ameliorates Inflammation and Promotes the Release of Monoamine Neurotransmitters in the Gut-Brain Axis of Schistosoma mansoni-Infected Mice
    • Authors: Mehran, H.S., Nady, S., Kassab, R.B., Ahmed-Farid, O.A., El-Hennamy, R.E.
    • Journal: Journal of Neuroimmune Pharmacology
    • Year: 2024
    • Volume: 19
    • Issue: 1
    • Pages: 37
    • Citations: 0
  • Publication Title: Anti-depressant effect of Naringenin-loaded hybridized nanoparticles in diabetic rats via PPARγ/NLRP3 pathway
    • Authors: El-Marasy, S.A., AbouSamra, M.M., Moustafa, P.E., Galal, A.F., Farouk, H., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 13559
    • Citations: 0
  • Publication Title: The study of wound healing activity of Thespesia populnea L. bark, an approach for accelerating healing through nanoparticles and isolation of main active constituents
    • Authors: Abdel Halim, M.B., Eid, H.H., El Deeb, K.S., Ahmed-Farid, O.A., El Messiry, H.M.
    • Journal: BMC Complementary Medicine and Therapies
    • Year: 2024
    • Volume: 24
    • Issue: 1
    • Article Number: 85
    • Citations: 0
  • Publication Title: Eugenol alleviates acrylamide-induced rat testicular toxicity by modulating AMPK/p-AKT/mTOR signaling pathway and blood–testis barrier remodeling
    • Authors: Saleh, D.O., Baraka, S.M., Jaleel, G.A.A., Hassan, A., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 1910
    • Citations: 1
  • Publication Title: Gastro-Protective, Antioxidant, and Anti-Inflammatory Potential of Three Vegetable Oils Against Indomethacin-Induced Gastric Ulceration in Rats: in Vivo and in Vitro Study
    • Authors: Mohamed, M.M., Ahmed-Farid, O.A.
    • Journal: Egyptian Journal of Chemistry
    • Year: 2024
    • Volume: 67
    • Issue: 7
    • Pages: 341–359
    • Citations: 0
  • Publication Title: A combined administration of GABA agonist and L-histidine synergistically alleviates obesity-induced neuro-lipotoxicity and distorted metabolic transcriptome
    • Authors: Al-Malki, E.S., Ahmed-Farid, O.A., Moustafa, M.M.A., Linhardt, R.J., Warda, M.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02177
    • Citations: 0
  • Publication Title: Tolerability of Artemisia absinthium in anorexia: Targeting of neuronal appetite and satiety in zinc deficiency diet rat model
    • Authors: El-bakry, K.A.-E.K.M., Bahnasawy, M.H., Deef, L.E., Ahmed-Farid, O.A.-H., El-Naeli, S.S.B.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02162
    • Citations: 0
  • Publication Title: Zinc Oxide Nanoparticles Attenuated Neurochemical and Histopathological Alterations Associated with Aluminium Chloride Intoxication in Rats
    • Authors: Attia, F.M., Kassab, R.B., Ahmed-Farid, O.A., Abdel Moneim, A.E., El-Yamany, N.A.
    • Journal: Biological Trace Element Research
    • Year: 2024
    • Volume: (in press)
    • Citations: 0
  • Publication Title: Neurological study on the effect of CeNPs and/or La Cl3 on adult male albino rats
    • Authors: Abdel-Rahman, M., Elmasry, H.M., Ahmed-Farid, O.A., Hegazy, S.M., Rezk, M.M.
    • Journal: Journal of Trace Elements in Medicine and Biology
    • Year: 2024
    • Volume: 81
    • Article Number: 127323
    • Citations: 2
  • Publication Title: Nanoliposomal amino acids counteracting protein malnutrition induced hematopoietic and hepatic complications
    • Authors: Ahmed, R.F., Elbaset, M.A., Farouk, H., Ahmed-Farid, O.A.H., Nasr, M.
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2023
    • Volume: 89
    • Article Number: 105051
    • Citations: 0

 

Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award

Ms. Sanja Stuhldreier | Social Media Marketing Communication | Best Researcher Award

Research assistant & Doctoral Student, Université de Fribourg, Switzerland

Ms. Sanja Stuhldreier, a PhD candidate in Marketing at Université de Fribourg, Switzerland, stands out for her innovative research in customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, and a Bachelor’s in International Business Studies from Universität Paderborn, complemented by international research experience at Harvard University. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her diverse professional background spans marketing project management, visual merchandising, and content creation. Ms. Stuhldreier is also multilingual, fluent in German, English, and French, and holds additional qualifications in psychology and university teaching. Her blend of academic prowess, practical experience, and commitment to education positions her as a formidable candidate for the Best Researcher Award.

Profile

ORCID Profile

Education

Ms. Sanja Stuhldreier’s educational background is distinguished by a strong focus on marketing and communication. She is currently pursuing a PhD in Marketing at Université de Fribourg, Switzerland, where her research centers on customer-oriented marketing and corporate communication on social networks. Her academic journey includes a Master’s degree in Marketing and Sales from Université de Haute-Alsace and Hochschule Niederrhein, which provided her with a solid foundation in marketing strategies and sales techniques. She also holds a Bachelor’s degree in International Business Studies from Universität Paderborn, equipping her with a broad understanding of global business practices. Additionally, Ms. Stuhldreier has participated in an international research project at Harvard University, further enriching her academic experience. Her diverse educational background is complemented by a Certificate in “Psychology: Social Processes and Work Environment” from FernUniversität Hagen and a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” enhancing her expertise in both psychological dynamics and innovative teaching methodologies.

Professional Experience

Ms. Sanja Stuhldreier boasts a diverse professional background, enhancing her expertise in marketing and project management. Since October 2020, she has served as a full-time faculty member at Université de Fribourg, where she teaches “Data Analysis with SPSS,” supervises student theses, and delivers presentations at international conferences. Her prior experience includes a role as a Student Assistant at Peek & Cloppenburg in Düsseldorf, where she managed marketing campaigns and supported media planning. Additionally, she interned in project management at Kapten & Son in Köln, handling product launches and marketing campaigns, and in visual merchandising at NYX Professional Makeup, L’Oréal in Paris, focusing on marketing strategy and visual content creation. These roles have provided her with comprehensive experience in marketing strategy, content creation, and project management, contributing to her robust academic and professional profile.

Additional Qualifications

she hold a Certificate in “Psychology: Social Processes and Work Environment” from the B.Sc. Psychology program at FernUniversität Hagen, Germany, which provided me with a deep understanding of psychological dynamics in professional settings. Additionally, she earned a Diploma of Advanced Studies in “University Teaching and Instructional Technologies,” equipping me with advanced skills in educational methodologies and technology integration for effective teaching.

Publications Top Notes

  1. Unlocking (re)purchase potential through corporate responsiveness on social networks: The role of perceived customer orientation
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  2. How does the corporate response rate to random consumer comments affect (re)purchase intentions of social network users? The role of perceived customer orientation
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  3. Social media marketing communication: Do purchase intentions depend on corporate response strategies? The role of perceived response appropriateness
    • Authors: Sanja Maria Stuhldreier
    • Year: 2024
  4. Effects of corporate response patterns on social networks on brand attitudes and purchase intentions of observing consumers
    • Authors: Sanja Maria Stuhldreier
    • Year: 2023
  5. Effects of complaint management strategies on social networks on observers’ emotional attachment and brand commitment
    • Authors: Sanja Maria Stuhldreier
    • Year: 2022

 

 

Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award

Mrs. Shichang Liu | Surgical nursing | Health Innovator’s Leadership Award

Nurse at The First People’s Hospital, China

Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, has over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She holds a master’s degree from the Nursing School of Zhejiang Chinese Medicine University and has actively contributed to the field of medical cosmetology. Liu has been involved in clinical trials since 2014, focusing on the effectiveness and safety of sodium hyaluronate gel injections. Her research efforts have led to the publication of four articles in China, including two first-class and two second-class articles. Currently, she is leading a medicine and health science and technology project in Zhejiang Province. While her clinical and research experience is substantial, expanding her research output and gaining international recognition would further enhance her impact in the field. Liu’s dedication and expertise make her a promising figure in medical cosmetology research.

Education

Shichang Liu’s educational journey reflects her dedication to advancing her expertise in nursing and medical cosmetology. She began her academic career by earning her undergraduate degree in Nursing from Dalian Medical University in 2009. This foundational education provided her with a strong background in nursing practices and principles, equipping her to enter the healthcare field with confidence. Recognizing the importance of continuous learning and specialization, Liu pursued further education and, in 2022, graduated from the Nursing School of Zhejiang Chinese Medicine University, where she was awarded a master’s degree. Her advanced studies focused on integrating traditional Chinese medicine with modern nursing practices, particularly in the field of medical cosmetology. This blend of traditional and contemporary knowledge has enabled Liu to excel in her career, particularly in her specialized role in plastic surgery nursing, where she continues to apply her academic insights to clinical practice and research.

Professional Experience

Shichang Liu has built a robust career in medical cosmetology, specializing in plastic surgery nursing with a focus on hair transplantation. Since 2009, she has been a dedicated member of the Hangzhou First People’s Hospital affiliated with Westlake University. Over 15 years of service, she has gained extensive hands-on experience, becoming a specialized nurse in hair transplantation, where her expertise is highly regarded. Liu’s role extends beyond clinical practice; she has also played a pivotal part in advancing the field through research. As a research nurse since 2014, she has contributed to several clinical trials assessing the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Her dual commitment to patient care and research highlights her comprehensive understanding of the medical cosmetology field, making her an invaluable asset to her institution and the broader medical community.

Research Interest

Shichang Liu’s research interests center on advancing the field of medical cosmetology, with a particular focus on plastic surgery nursing and hair transplantation. Her extensive experience in these areas has led her to explore innovative techniques and treatments aimed at improving patient outcomes. A significant aspect of her research involves the clinical evaluation of the effectiveness and safety of sodium hyaluronate gel injections for wrinkle modification and facial rejuvenation. Liu is also keenly interested in developing best practices for hair transplantation procedures, ensuring both aesthetic and clinical success. Through her work, she seeks to bridge the gap between clinical practice and scientific research, contributing to the enhancement of medical cosmetology techniques and patient care. Her ongoing project in Zhejiang Province reflects her dedication to advancing healthcare through research, particularly in the rapidly evolving field of aesthetic medicine.

Research Skills

Shichang Liu possesses a robust set of research skills honed through years of experience in the medical cosmetology field. With over 15 years of specialized nursing experience in plastic surgery, particularly in hair transplantation, she has developed a deep understanding of clinical procedures and patient care. Her role as a research nurse since 2014 has equipped her with expertise in conducting clinical trials, specifically focusing on the effectiveness and safety of sodium hyaluronate gel injections for wrinkle and facial contour modifications. Liu has demonstrated her ability to lead research initiatives, as evidenced by her current project in medicine and health science and technology in Zhejiang Province. Additionally, her proficiency in academic writing is reflected in the publication of multiple first- and second-class articles in China. Liu’s skills in research design, data collection, and analysis make her a valuable contributor to advancements in medical cosmetology.

Award and Recognition

Shichang Liu, a Nurse-in-Charge at Hangzhou First People’s Hospital affiliated with Westlake University, is a distinguished professional in the field of medical cosmetology with over 15 years of specialized experience in plastic surgery nursing, particularly in hair transplantation. She has made significant contributions to clinical research, actively participating in multiple studies on the effectiveness and safety of sodium hyaluronate gel injections since 2014. Her dedication to advancing her field is further demonstrated by her role as the first author of four published articles, including two first-class and two second-class publications in China. Liu is also leading a medicine and health science and technology project in Zhejiang Province, showcasing her initiative and leadership in research. Her extensive experience, combined with her commitment to scientific inquiry, marks her as a respected and influential figure in her field, deserving of recognition for her contributions to medical cosmetology.

Conclusion

Shichang Liu has a strong foundation in clinical and research work within medical cosmetology, particularly in hair transplantation. Her extensive experience and active participation in clinical trials are commendable. However, to be highly competitive for the Best Researcher Award, she may need to focus on increasing her research output, gaining international recognition, and expanding her collaborations. Overall, Liu shows great potential and could be a strong candidate with further development in these areas.

 

 

 

Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award

Assoc Prof Dr. Fatemeh Kazemi-Lomedasht | Medical Biotechnology | Best Researcher Award

Researcher of Pasteur Institute of Iran, Iran.

Fatemeh Kazemi-Lomedasht is an accomplished Associate Professor at the Biotechnology Research Center, Pasteur Institute of Iran. She holds a Ph.D. in Medical Biotechnology from Pasteur Institute and an M.Sc. in the same field from Tabriz University of Medical Sciences. Her research focuses on cancer biology, monoclonal antibodies, and drug delivery systems, particularly in developing nanobodies and targeted cancer therapies. She has authored numerous high-impact publications in journals such as TOXICON and Current Pharmaceutical Biotechnology. Her work includes innovative studies on nanobody development and targeted therapeutic strategies. Fatemeh is an active member of the American Chemical Society, Health Biotechnology Society, and Biotechnology Society, reflecting her engagement with the scientific community. Her contributions have advanced the field of biotechnology, and she continues to lead research efforts aimed at improving therapeutic and diagnostic applications.

Profile
Education

Fatemeh Kazemi-Lomedasht pursued her education in medical biotechnology with distinction. She completed her Ph.D. at the Pasteur Institute of Iran in 2015, where her dissertation focused on generating and selecting single-domain monoclonal antibodies (nanobodies) against vascular endothelial growth factor (VEGF) using phage display technology. This work contributed significantly to the field of targeted cancer therapies. Prior to her doctoral studies, she earned her M.Sc. in Medical Biotechnology from Tabriz University of Medical Sciences in 2011. Her master’s thesis investigated the anticancer properties of diferuloyl methane-containing nanoparticles and their effect on human telomerase reverse transcriptase gene expression in breast cancer cell lines. Both her Ph.D. and M.Sc. studies provided her with a strong foundation in molecular techniques, cancer research, and drug development, establishing her as a prominent researcher in her field.

Professional Experience

Fatemeh Kazemi-Lomedasht has had a distinguished career in the field of biotechnology. She has served as an Associate Professor at the Biotechnology Research Center of the Pasteur Institute of Iran since 2022, where she leads innovative research in cancer therapies, monoclonal antibodies, and drug delivery systems. Prior to this, she was an Assistant Professor at the same institution from 2015 to 2022, contributing significantly to the advancement of biotechnology research. During her tenure, she has been involved in groundbreaking studies on nanobodies and targeted cancer treatments, reflecting her expertise and leadership in the field. Her role includes overseeing research projects, mentoring junior researchers, and engaging with the scientific community. Fatemeh’s professional experience underscores her commitment to advancing biotechnological solutions and her influence in shaping research directions within her area of specialization

Research Interest

Fatemeh Kazemi-Lomedasht’s research interests are deeply rooted in advancing cancer research and biotechnology. Her work primarily focuses on the development and application of monoclonal antibodies and nanobodies for targeted cancer therapies, aiming to improve drug discovery and delivery methods. She is particularly interested in drug delivery systems that enhance the precision and efficacy of cancer treatments. Her research also delves into epitope mapping, which plays a crucial role in understanding protein interactions and designing targeted therapeutic agents. Kazemi-Lomedasht’s expertise extends to innovative approaches in developing functional nanobodies and evaluating their potential in combating various forms of cancer. Through her work, she seeks to contribute to the development of novel therapeutic strategies that can significantly impact cancer treatment and drug development, reflecting her commitment to advancing the field of biotechnology and improving patient outcomes.

Research Skills

Fatemeh Kazemi-Lomedasht possesses a comprehensive set of research skills crucial for advancing biotechnology. Her expertise encompasses a range of molecular techniques, including mammalian cell culture, isolation of primary cells, and cloning and expression of recombinant proteins. She is proficient in phage display technology, which has been pivotal in her work on generating and characterizing nanobodies. Additionally, Fatemeh is skilled in enzyme-linked immunosorbent assays (ELISA) and bioinformatics, which enhance her ability to analyze complex biological data. Her research frequently involves drug discovery and targeted delivery systems, reflecting her capability in designing and evaluating therapeutic agents. Her proficiency in these techniques, combined with her experience in epitope mapping and drug delivery research, highlights her ability to conduct high-impact research in the field of biotechnology and cancer therapeutics.

 Awards and Recognition

Fatemeh Kazemi-Lomedasht has garnered significant recognition for her contributions to the field of biotechnology. Her innovative research, particularly in monoclonal antibodies and drug discovery, has been well acknowledged in the scientific community. While specific awards are not listed, her impactful publications in high-profile journals such as TOXICON and Current Pharmaceutical Biotechnology highlight her contributions. Her work on nanobodies and targeted cancer therapies has been pivotal, reflecting her excellence in research. Additionally, her role as an Associate Professor at the Biotechnology Research Center of Pasteur Institute of Iran and her membership in prestigious scientific societies like the American Chemical Society, Health Biotechnology Society, and Biotechnology Society underscore her professional standing and influence. These achievements reflect her commitment to advancing biotechnology and her recognition as a leading researcher in her field.

Conclusion

Fatemeh Kazemi-Lomedasht is a highly qualified candidate for the Best Researcher Award, given her impressive research background, significant publications, and innovative contributions to biotechnology. Her strengths in cancer research and monoclonal antibodies are notable, and her role as an Associate Professor underscores her leadership in the field. Addressing areas for improvement, such as broadening the impact of her work and enhancing interdisciplinary collaboration, could further elevate her candidacy. Overall, her achievements and contributions make her a strong contender for this award.

Publications Top Notes

  • “Single-domain antibodies or nanobodies: a class of next-generation antibodies”
    • Authors: F Khodabakhsh, M Behdani, A Rami, F Kazemi-Lomedasht
    • Journal: International Reviews of Immunology
    • Year: 2018
    • Citations: 101
  • “Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody”
    • Authors: F Kazemi-Lomedasht, M Behdani, KP Bagheri, M Habibi-Anbouhi, …
    • Journal: Molecular Immunology
    • Year: 2015
    • Citations: 82
  • “Comparison of inhibitory effect of curcumin nanoparticles and free curcumin in human telomerase reverse transcriptase gene expression in breast cancer”
    • Authors: A Rami, N Zarghami
    • Journal: Advanced Pharmaceutical Bulletin
    • Year: 2013
    • Citations: 76
  • “Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs”
    • Authors: E Karami, M Behdani, F Kazemi-Lomedasht
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2020
    • Citations: 74
  • “An overview on application of phage display technique in immunological studies”
    • Authors: A Rami, M Behdani, N Yardehnavi, M Habibi-Anbouhi, …
    • Journal: Asian Pacific Journal of Tropical Biomedicine
    • Year: 2017
    • Citations: 67
  • “The first report on transcriptome analysis of the venom gland of Iranian scorpion, Hemiscorpius lepturus”
    • Authors: F Kazemi-Lomedasht, V Khalaj, KP Bagheri, M Behdani, …
    • Journal: Toxicon
    • Year: 2017
    • Citations: 47
  • “Nanobodies as novel therapeutic agents in envenomation”
    • Authors: E Alirahimi, F Kazemi-Lomedasht, D Shahbazzadeh, M Habibi-Anbouhi, …
    • Journal: Biochemical and Biophysical Journal (BBA)-General Subjects
    • Year: 2018
    • Citations: 42
  • “Preparation and characterization of a novel nanobody against T-cell immunoglobulin and mucin-3 (TIM-3)”
    • Authors: V Homayouni, M Ganjalikhani-Hakemi, A Rezaei, H Khanahmad, …
    • Journal: Iranian Journal of Basic Medical Sciences
    • Year: 2016
    • Citations: 41
  • “Development of a mono‐specific anti‐VEGF bivalent nanobody with extended plasma half‐life for treatment of pathologic neovascularization”
    • Authors: A Sadeghi, M Behdani, S Muyldermans, M Habibi‐Anbouhi, …
    • Journal: Drug Testing and Analysis
    • Year: 2020
    • Citations: 33
  • “Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function”
    • Authors: F Kazemi-Lomedasht, S Muyldermans, M Habibi-Anbouhi, M Behdani
    • Journal: Iranian Journal of Basic Medical Sciences
    • Year: 2018
    • Citations: 33

Samia Ahmed | Biological Sciences | Best Researcher Award

Prof. Samia Ahmed | Biological Sciences | Best Researcher Award

Research Assistant of Tabriz university of medical sciences, Iran.

Samia Abdel-Aziz Ahmed Sayed is a distinguished Professor of Microorganisms Chemistry at the National Research Centre in Cairo, Egypt. With a strong academic background, including a Ph.D. in Biochemistry from Cairo University, she has significantly contributed to the field of microbial enzymes. Her research focuses on the production, stabilization, and application of industrially important enzymes derived from microorganisms. Prof. Sayed has led several projects, including those on enzyme production from agricultural residues and waste treatment using microbial laccase. She has actively participated in numerous international conferences and workshops, showcasing her work and leadership. Additionally, she has supervised multiple M.Sc. and Ph.D. dissertations, enhancing the academic growth of emerging researchers. Her extensive publication record in reputed journals underscores her expertise and impact in microbial biotechnology and enzyme chemistry. Prof. Sayed’s contributions make her a strong candidate for the Best Researcher Award.

Profile
Education

Dr. Samia Abdel-Aziz Ahmed Sayed holds a robust educational background in biochemistry and agricultural sciences. She earned her Bachelor of Science in Agriculture with a focus on Biochemistry from Cairo University in 1988. Her commitment to advancing her expertise led her to pursue a Master’s degree in Agriculture Science, also specializing in Biochemistry, which she completed in 1994. Her master’s thesis concentrated on biochemical studies of microbial proteolytic enzymes. Furthering her academic journey, she achieved a Ph.D. in Agriculture Science with a concentration in Biochemistry from Cairo University in 2003. Her doctoral research focused on biochemical studies of industrial enzymes. Dr. Sayed’s educational qualifications have laid a strong foundation for her career as a Professor of Microorganisms Chemistry at the National Research Centre, Cairo, where she continues to contribute significantly to her field.

Professional Experience

Dr. Samia Abdel-Aziz Ahmed Sayed is a distinguished professor at the National Research Centre in Cairo, Egypt, specializing in Microorganisms Chemistry. She holds a B.Sc., M.Sc., and Ph.D. in Agriculture Science with a focus on Biochemistry from Cairo University. Her professional journey includes pivotal roles in various research projects, such as the production and stabilization of microbial enzymes and the application of agricultural residues in enzyme production. She has served as Principal Investigator and Co-Principal Investigator in multiple projects, including those on enzyme immobilization and the recycling of agricultural and industrial wastes. Dr. Sayed’s expertise extends to supervising numerous M.Sc. and Ph.D. students and participating in diverse academic activities, including conferences and workshops. Her contributions to the field are underscored by her active role in enhancing the stability and activity of industrial enzymes through innovative research methodologies.

Research Interest

Professor Samia Abdel-Aziz Ahmed Sayed’s research focuses on the biochemical and industrial applications of microbial enzymes. Her work primarily explores the production, stabilization, and application of enzymes derived from microorganisms, with a particular emphasis on those utilizing agricultural and industrial residues. She investigates enzyme systems such as proteases, amylases, and laccases, and their potential uses in various industries, including textiles and food processing. Additionally, her research delves into the environmental impact of enzyme applications, aiming to develop sustainable solutions for waste management through the recycling of agro-industrial residues. Professor Sayed’s projects include optimizing enzyme activity and stability, as well as developing innovative methods for enzyme immobilization and application. Her contributions extend to enhancing the understanding of enzyme functionality and improving industrial processes, reflecting her commitment to advancing biotechnological solutions for practical and environmental challenges.

Research Skills

Samia Abdel-Aziz Ahmed Sayed possesses extensive research skills, particularly in the biochemistry and enzymology fields. Her expertise encompasses microbial enzyme production, stabilization, and application in various industries, including agriculture and textiles. She has demonstrated proficiency in utilizing agricultural residues for enzyme production, optimizing enzyme properties, and employing advanced techniques such as enzyme immobilization and modification. Her work includes leading significant projects on enzyme recycling and waste management, highlighting her skills in project management and innovation. Samia’s research is further supported by her contributions to numerous high-impact publications and her role in supervising graduate research, reflecting her ability to guide and mentor emerging scientists. Additionally, her active participation in conferences and workshops underscores her commitment to staying abreast of current advancements and sharing knowledge within the scientific community.

Awards and Recognition

Samia Abdel-Aziz Ahmed Sayed, a distinguished professor at the National Research Centre, Cairo, Egypt, has garnered significant recognition for her contributions to biochemistry and microbial enzyme research. Her notable achievements include participation in multiple high-impact research projects, such as those focused on microbial enzyme production and waste recycling. Sayed’s work has been widely recognized through numerous conference presentations, workshops, and her role in various editorial boards. She has been acknowledged for her expertise in enzyme stabilization and production, with several publications in esteemed journals. Her commitment to advancing scientific knowledge and her active involvement in international and national research communities underscore her standing as a leading researcher in her field. Sayed’s innovative research and dedication have earned her a respected place among top scientists in biochemistry and environmental biotechnology.

Conclusion

Samia Abdel-Aziz Ahmed Sayed is a highly qualified candidate for the Research for Best Researcher Award due to her extensive research experience, innovative projects, significant publications, leadership in academia, and active participation in the scientific community. To further strengthen her candidacy, she could focus on expanding international collaborations, seeking additional funding, and enhancing public outreach efforts. Overall, her contributions to science and her leadership in research make her a strong contender for this prestigious award.

Publications Top Notes

  1. Catalytic, Kinetic, and Thermodynamic Properties of Pleurotus Ostreatus NRRL 3501 Laccase Immobilized on Clinoptilolite Nanoparticles and its Application in Dye Decolorization
    • Authors: Wehaidy, H.R., Saleh, S.A.A., Abdel Wahab, W.A., El-Hennawi, H.M., Abdel-Naby, M.A.
    • Year: 2024
  2. Date Nawah Powder as a Promising Waste for β-Mannanase Production from a New Isolate Aspergillus niger MSSFW, Statistically Improving Production and Enzymatic Characterization
    • Authors: Saleh, S.A.A., Mostafa, F.A., Ahmed, S.A., Salama, W.H., Abdel Wahab, W.A.
    • Year: 2024
  3. Evaluation of Lupine Seeds (Lupinus albus L.) Neutral Extract as a Texture Improver in Low-Fat Yogurt Production
    • Authors: Ahmed, S.A., Helmy, W.A., Ibrahim, O.A.
    • Year: 2024
    • Citations: 0
  4. Low-Lactose Yoghurt Production Using β-Galactosidase: An Integrated Study for the Enzyme and Its Application
    • Authors: Abdel Wahab, W.A., Ahmed, S.A., Kholif, A.M.M., El Ghani, S.A., Wehaidy, H.R.
    • Year: 2024
  5. Preparation of Bioactive Oligosaccharides from Mallow Residues by Enzymes Mixture of Isolated Aspergillus flavus B2 and Evaluation of Their Biological Activities
    • Authors: Saleh, S.A.A., Ahmed, S.A., Mostafa, F.A., Taie, H.A.A., Abdel Wahab, W.A.
    • Year: 2024
  6. Antioxidant Capacity and Antitumor Activity of the Bioactive Protein Prepared from Orange Peel Residues as a By-Product Using Fungal Protease
    • Authors: Ahmed, S.A., Taie, H.A.A., Abdel Wahab, W.A.
    • Year: 2023
    • Citations: 14
  7. Statistical Optimization of Enzyme Cocktail Production Using Jew’s Mallow Stalks Residues by a New Isolate Aspergillus flavus B2 via Statistical Strategy and Enzymes Characterization
    • Authors: Abdel Wahab, W.A., Mostafa, F.A., Ahmed, S.A., Saleh, S.A.A.
    • Year: 2023
    • Citations: 6
  8. Protease Immobilization on a Novel Activated Carrier Alginate/Dextrose Beads: Improved Stability and Catalytic Activity via Covalent Binding
    • Authors: Abdella, M.A.A., Ahmed, S.A., Hassan, M.E.
    • Year: 2023
    • Citations: 14
  9. Statistical Improvement of Protease Production from a New Isolate Bacillus thuringiensis Strain-MA8 and Its Application in the Production of Enzyme-Modified Cheese
    • Authors: Abdella, M.A.A., Ahmed, S.A., Ibrahim, O.A.
    • Year: 2023
    • Citations: 9
  10. Kinetic, Catalytic and Thermodynamic Properties of Immobilized B. Circulans 25 Milk Clotting Enzyme on Activated Chitosan Polymer and Its Ability to Form Milk Curds
    • Authors: Ahmed, S.A., Abdel-Naby, M.A., Abdel-Fattah, A.F.
    • Year: 2022
    • Citations: 1

 

 

Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Dr. Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Surgery Resident and Fleni, Argentina.

Dr. Mariano Marrodan, MD, MSc, is a distinguished neurologist based in Buenos Aires, Argentina, with a robust background in neuroimmunology and multiple sclerosis. Currently, he serves as a Staff Neurologist at Fleni and Hospital Zonal General de Agudos Domingo Mercante. Dr. Marrodan holds a Master’s in Neuroimmunology from Universidad Autónoma de Barcelona and has completed notable fellowships at Cemcat and FLENI. His clinical research focuses on multiple sclerosis, autoimmune encephalitis, and neuroimmunology, with significant contributions to the understanding of Susac Syndrome and neuromyelitis optica spectrum disorders. He has published extensively in prestigious journals and is actively involved in mentoring and teaching, including directing neuroimmunology courses and coordinating virtual neuroimmunology rounds. Dr. Marrodan’s work, recognized through various awards, showcases his impact on advancing neurological research and improving patient care in Argentina and beyond.

Profile

Education

Dr. Mariano Marrodan’s educational background is distinguished by rigorous training and specialization in neurology and neuroimmunology. He earned his medical degree from Austral University in Buenos Aires, Argentina, graduating with honors in 2014. Following this, Dr. Marrodan completed his Neurology Residency at the Institute for Neurological Research Raul Carrea – FLENI from 2014 to 2018. His pursuit of specialized knowledge led him to a Clinical Fellowship in Multiple Sclerosis and Neuroimmunology at FLENI, which he completed in 2021. To further deepen his expertise, he pursued a Master’s in Neuroimmunology at the Universidad Autónoma de Barcelona (UAB), Spain, from 2022 to 2023. Additionally, he undertook a Multiple Sclerosis Research Fellowship at the Centre d’Esclerosi Múltiple de Catalunya (Cemcat) in Barcelona during the first half of 2023, augmenting his skills in advanced neuroimmunological research.

Professional Experience

Dr. Mariano Marrodan is a distinguished neurologist with extensive professional experience in both clinical and academic settings. Currently, he serves as a Staff Neurologist at Fleni in Buenos Aires, where he is involved in general neurology and the division of Multiple Sclerosis and Neuroimmunology. His role at Fleni began in June 2021 and includes contributions to inpatient services and specialized neuroimmunology care. Additionally, Dr. Marrodan works at Hospital Zonal General de Agudos Domingo Mercante and has held various roles at Fleni, including Junior Attending and Emergency Department Neurologist. His prior experience includes serving as a Staff Neurologist at the neurological rehabilitation center “La Horqueta” and as Neurology Chief Resident at FLENI. Dr. Marrodan’s background reflects a strong commitment to advancing neurology through clinical practice, research, and education.

Research Interests

Dr. Mariano Marrodan’s research focuses on advancing our understanding of neuroimmunological and neurodegenerative diseases, particularly Multiple Sclerosis (MS) and related conditions. His work emphasizes the pathophysiology, diagnostic strategies, and treatment outcomes of MS and neuromyelitis optica spectrum disorders (NMOSD). Dr. Marrodan is particularly interested in exploring the impact of novel therapeutic approaches and assessing their efficacy in real-world settings. His research involves extensive clinical and observational studies, such as evaluating the effects of oral Cladribine on MRI lesions in MS patients and developing a Latin-American database for Susac Syndrome. He is also engaged in the International MS Microbiome Study and the Argentinean Multiple Sclerosis Registry, which aim to deepen the understanding of disease mechanisms and treatment responses. Through his innovative research, Dr. Marrodan seeks to improve patient care and contribute to the global knowledge base on neuroimmunological disorders.

Research Skills

Dr. Mariano Marrodan exhibits exceptional research skills across multiple dimensions of neurology. His expertise spans clinical and basic research, with a notable focus on multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), and autoimmune encephalitis. Dr. Marrodan excels in designing and conducting observational and interventional studies, such as his principal investigator role in studies on oral Cladribine and Susac Syndrome. His proficiency extends to statistical analysis and study design, evidenced by his involvement in large-scale registries and multicentric collaborations. Dr. Marrodan’s adeptness in using advanced diagnostic tools, including MRI and immunological assessments, complements his strong publication record in high-impact journals. His leadership in coordinating neuroimmunology courses and mentoring junior researchers further underscores his commitment to advancing knowledge and fostering scientific growth. Dr. Marrodan’s multifaceted research skills make him a distinguished contributor to the field of neurology.

Awards and Recognition 🏆

Dr. Marrodan has received recognition through his roles in prestigious research projects and his contributions to significant publications. His continued involvement in high-profile academic and clinical roles indicates a respected position within his field.

Conclusion 🏅

Dr. Mariano Marrodan’s extensive research contributions, collaborative efforts, and applied clinical research make him a compelling candidate for the Best Researcher Award. His work not only advances the field of neurology but also impacts clinical practice and patient outcomes on a regional and global scale.

Publications Top Notes

  • Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)
    • Authors: Carnero Contentti, E., Lopez, P.A., Patrucco, L., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
  • Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Caride, A., Rojas, J.I.
    • Year: 2024
  • Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings
    • Authors: Pestchanker, C., Bertado Cortez, B., Lana Peixoto, M.A., Lopez, P., Carnero Contentti, E.
    • Year: 2024
  • Selection of disease modifying therapies in multiple sclerosis based on patient’s age and disease activity: Data from a nationwide registry
    • Authors: Piedrabuena, M.A., Correale, J., Fiol, M., Martinez, C.M., Ysrraelit, M.C.
    • Year: 2024
  • Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
    • Authors: Camerlingo, S., Rubinstein, F., Celia Ysrraelit, M., Silva, B.A., Alonso, R.
    • Year: 2024
    • Citations: 1
  • Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
    • Authors: Carnero Contentti, E., López, P.A., Pappolla, A., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
    • Citations: 1
  • Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
    • Authors: Marrodan, M., Calandri, I.L., Bocancea, D.I., Fiol, M.P., Correale, J.
    • Year: 2024
  • Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 4
  • Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome
    • Authors: Plantone, D., Sabatelli, E., Locci, S., De Stefano, N., Iorio, R.
    • Year: 2023
    • Citations: 2
  • Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
    • Authors: Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 3